Large gap with delayed quotes
Analysis date: 12.12.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 09.09.2025.
Interest
Strong
Strong
Three stars since 04.11.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 31.10.2025 at a price of 102.00.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 31.10.2025.
4wk Rel Perf
12.22%
12.22%
The four-week dividend-adjusted overperformance versus SP500 is 12.22%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 15.07.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.18%.
Mkt Cap in $bn
5.54
5.54
With a market capitalization between $2 & $8bn, ARCOSA is considered a mid-cap stock.
G/PE Ratio
0.83
0.83
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
20.48
20.48
The estimated PE is for the year 2027.
LT Growth
16.77%
16.77%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
5
5
Over the last seven weeks, an average of 5 analysts provided earnings per share estimates.
Dividend Yield
0.18%
0.18%
The twelve month estimated dividend yield represents 3.70% of earnings forecasts.
Beta
98
98
For 1% of index variation, the stock varies on average by 0.98%.
Correlation
0.55
0.55
54.85% of stock movements are explained by index variations.
Value at Risk
25.89
25.89
The value at risk is estimated at USD 25.89. The risk is therefore 23.36%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
15.07.2025
15.07.2025